Comparison of the Efficacy and Safety of Low-molecular-weight Heparin and Dabigatran Ester in Anticoagulant Treatment of Non Valvular Atrial Fibrillation Patients

LENG Ming

PDF(1190 KB)
PDF(1190 KB)
Chinese And Foreign Medical Research ›› 2024, Vol. 22 ›› Issue (16) : 123-126. DOI: 10.14033/j.cnki.cfmr.2024.16.031
Experience

Comparison of the Efficacy and Safety of Low-molecular-weight Heparin and Dabigatran Ester in Anticoagulant Treatment of Non Valvular Atrial Fibrillation Patients

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 22(16): 123-126 https://doi.org/10.14033/j.cnki.cfmr.2024.16.031

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1190 KB)

Accesses

Citation

Detail

Sections
Recommended

/